Orchestra BioMed (OBIO) Stock Insights

OBIO price $5.99 +0.21 +3.63%

Ticker
OBIO
Price
$5.99
Change
+0.21 +3.63%
Market cap ?
$360.03M
Beta ?
0.52
Sector
Healthcare
Industry
Biotechnology

Fair value

OBIO fair value $6.39. Price $5.99. Price is 6% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 4.22M. Growth 10.23%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 60.11M. Net debt -18.73M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare OBIO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.40—129.43K
2026-08-10-0.38-0.3988.00K137.71K
2026-05-12-0.33-0.40110.00K918.71K
2026-03-120.12-0.3830.92M931.00K
2025-11-10-0.40-0.38861.00K741.40K
2025-08-12-0.50-0.51836.00K778.83K
2025-04-02-0.43-0.43253.00K522.33K
2025-03-26-0.37-0.43253.00K—
2024-11-12-0.41-0.44987.00K703.25K
2024-08-12-0.45-0.41778.00K850.00K
2024-05-13-0.38-0.40620.00K950.00K
2024-03-27-0.37-0.38262.00K994.50K
2023-11-13-0.38-0.39419.00K895.00K
2023-08-10-0.35-0.42915.00K706.00K
2023-05-12-0.40-0.281.16M680.00K
2023-01-25-2.08-3.141.10M1.18M
2022-11-14-3.71-3.141.16M1.18M
2022-08-15-0.25—401.00K—
2022-03-31-0.18—866.00K—
2021-12-31-0.00—-2.45M—
2021-09-30-0.00—1.33M—
2021-06-30-0.00—-978.00K—
2021-03-31-0.01—1.32M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Sherman DarrenSell15.00K$6.3695.40K
2026-09-10Hochman David PSell3.28K$5.8119.07K
2026-09-10Hochman David PSell3.28K$5.8119.07K
2026-09-03Hochman David PBuy10.00K$4.7947.90K
2026-09-01Sherman DarrenSell15.00K$4.9474.10K
2026-08-26Taylor Andrew LawrenceSell3.08K$5.2616.18K
2026-08-26Sherman DarrenSell4.92K$5.2625.91K
2026-08-26Sherman DarrenBuy2.00K$5.3310.66K
2026-08-26Aiello JoshuaSell203$5.261.07K
2026-08-12Pacitti DavidSell3.76K$4.4216.62K
2026-08-12Fain Eric SSell5.14K$4.4222.74K
2026-08-12Mack John ProsperSell4.88K$4.4221.59K
2026-08-12Cleary ChrisSell4.24K$4.4218.73K
2026-08-03Sherman DarrenSell15.00K$4.0961.35K
2026-07-01Sherman DarrenSell15.00K$4.2764.05K
2026-06-24Fain Eric SSell4.26K——
2026-06-24Pacitti DavidSell3.78K——
2026-06-24Cleary ChrisSell3.51K——
2026-06-24Mack John ProsperSell3.51K——
2026-06-23Fain Eric SBuy17.33K——
2026-06-23Fain Eric SBuy21.28K$4.0485.96K
2026-06-23Pacitti DavidBuy17.33K——
2026-06-23Pacitti DavidBuy21.28K$4.0485.96K
2026-06-23Cleary ChrisBuy42.55K$4.04171.91K
2026-06-23Connealy Pamela AnnBuy17.33K——
2026-06-23Connealy Pamela AnnBuy21.28K$4.0485.96K
2026-06-23Aryeh JasonBuy42.55K$4.04171.91K
2026-06-23Mack John ProsperBuy34.65K——
2026-06-10Taylor Andrew LawrenceSell36.35K$4.02146.14K
2026-06-10Hochman David PSell3.28K$4.0213.20K
2026-06-10Hochman David PSell3.28K$4.0213.20K
2026-06-01Hochman David PBuy5.00K$3.8319.15K
2026-06-01Sherman DarrenSell15.00K$3.8758.05K
2026-05-28Taylor Andrew LawrenceSell3.08K$3.9812.24K
2026-05-28Sherman DarrenSell4.92K$3.9819.60K
2026-05-18Aryeh JasonBuy665$3.752.49K
2026-05-15Aryeh JasonBuy8.97K$3.9034.99K
2026-05-15Hochman David PBuy5.00K$3.7718.85K
2026-05-14Fain Eric SBuy20.00K$4.1382.60K
2026-04-27RTW INVESTMENTS, LPBuy1.25M$0.00125
2026-04-27RTW INVESTMENTS, LPSell32$4.13132
2026-04-27RTW INVESTMENTS, LPSell1.25M$0.00125
2026-03-25Sherman DarrenSell33.32K$4.57152.26K
2026-03-25Aiello JoshuaSell241$4.571.10K
2026-03-25Hochman David PSell32.44K$4.57148.24K
2026-03-13Hochman David PBuy10.00K$4.2942.90K
2026-02-12Aiello JoshuaBuy70.00K$3.82267.40K
2026-02-12Sherman DarrenBuy397.00K——
2026-02-12Taylor Andrew LawrenceBuy181.00K——
2026-02-12Hochman David PBuy504.00K——
2026-02-05Cleary ChrisSell676$3.712.51K
2026-01-28Sherman DarrenBuy34.97K$2.8599.68K
2026-01-02Taylor Andrew LawrenceSell3.45K$4.3114.88K
2026-01-02Aiello JoshuaSell241$4.311.04K
2026-01-02Sherman DarrenSell5.59K$4.3124.08K
2025-12-10Taylor Andrew LawrenceSell8.67K$4.6740.49K
2025-12-10Hochman David PSell40.35K$4.67188.46K
2025-12-10Hochman David PSell3.28K$4.6715.33K
2025-11-25Taylor Andrew LawrenceSell3.07K$5.3516.43K
2025-11-25Sherman DarrenSell40.34K$5.35215.82K
2025-11-14Hochman David PBuy5.00K$4.0720.35K
2025-11-13Hochman David PSell3.28K$4.1813.72K
2025-11-13Hochman David PSell3.28K$4.1813.72K
2025-09-19Aryeh JasonBuy1.00K$2.452.45K
2025-09-17Aiello JoshuaSell203$2.46499
2025-09-17Taylor Andrew LawrenceSell16.10K$2.4639.61K
2025-09-17Hochman David PSell40.35K$2.4699.27K
2025-09-17Hochman David PSell3.28K$2.468.08K
2025-09-03Sherman DarrenSell40.34K$2.72109.72K
2025-08-25Fain Eric SBuy5.76K$2.6115.03K
2025-08-25Sherman DarrenBuy3.00K$2.627.86K
2025-08-25Taylor Andrew LawrenceBuy2.00K$2.555.10K
2025-08-21Hochman David PBuy6.00K$2.4914.94K
2025-08-07Taylor Andrew LawrenceBuy80.00K——
2025-08-07Aryeh JasonBuy15.00K——
2025-08-07Sherman DarrenBuy120.00K——
2025-08-07Connealy Pamela AnnBuy15.00K——
2025-08-07Mack John ProsperBuy15.00K——
2025-08-07Fain Eric SBuy7.50K——
2025-08-07Fain Eric SBuy7.50K——
2025-08-07Cleary ChrisBuy15.00K——
2025-08-07Hochman David PBuy100.00K——
2025-08-07Hochman David PBuy100.00K——
2025-08-07Pacitti DavidBuy15.00K——
2025-08-07Aiello JoshuaBuy15.00K——
2025-08-04RTW INVESTMENTS, LPBuy3.64M$0.00364
2025-08-04Hochman David PBuy20.00K$2.7555.00K
2025-08-01PERCEPTIVE ADVISORS LLCBuy700.00K$2.751.93M
2025-08-01PERCEPTIVE ADVISORS LLCBuy1.50M$0.00150
2025-06-26Fain Eric SSell2.68K$3.058.18K
2025-06-24Aryeh JasonBuy12.42K——
2025-06-24Aryeh JasonBuy36.80K$3.22118.49K
2025-06-24Cleary ChrisBuy36.80K$3.22118.49K
2025-06-24Cleary ChrisBuy12.42K——
2025-06-24Mack John ProsperBuy36.80K$3.22118.49K
2025-06-24Mack John ProsperBuy12.42K——
2025-06-24Connealy Pamela AnnBuy36.80K$3.22118.49K
2025-06-24Connealy Pamela AnnBuy12.42K——
2025-06-24Fain Eric SBuy12.42K——
2025-06-24Fain Eric SBuy36.80K$3.22118.49K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 81, holders +15 vs prior quarter. Ownership 43.95%.

HolderSharesChangeChange %Value
RTW INVESTMENTS, LP9.56M1.25M+15.05%41.23M
PERCEPTIVE ADVISORS LLC5.04M00.00%21.74M
BLACKROCK, INC.2.51M1.87M+294.89%10.83M
VANGUARD CAPITAL MANAGEMENT LLC2.02M-181.40K-8.23%8.73M
GEODE CAPITAL MANAGEMENT, LLC1.01M522.42K+107.61%4.35M
ALYESKA INVESTMENT GROUP, L.P.1.00M00.00%4.32M
PROPEL BIO MANAGEMENT, LLC896.70K00.00%3.87M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC642.15K642.15KNew2.77M
STATE STREET CORP516.05K346.64K+204.62%2.23M
RICE HALL JAMES & ASSOCIATES, LLC424.00K405.00K+2131.46%1.83M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC349.54K84.05K+31.66%1.51M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.349.54K349.54KNew1.51M
NORTHERN TRUST CORP343.64K225.37K+190.55%1.48M
UBS GROUP AG325.77K275.46K+547.53%1.41M
VANGUARD FIDUCIARY TRUST CO292.25K57.04K+24.25%1.26M
VANGUARD PORTFOLIO MANAGEMENT LLC274.97K274.97KNew1.19M
KNOTT DAVID M JR253.65K00.00%1.09M
FLAT FOOTED LLC251.37K251.37KNew1.08M
SIMPLIFY ASSET MANAGEMENT INC.219.39K00.00%946.65K
GOLDMAN SACHS GROUP INC179.61K24.36K+15.69%775.00K
DAFNA CAPITAL MANAGEMENT LLC126.84K00.00%547.32K
RENAISSANCE TECHNOLOGIES LLC90.00K19.10K+26.94%388.35K
IFP ADVISORS, INC89.61K-9.28K-9.38%386.66K
DAYTONA STREET CAPITAL LLC96.40K43.80K+83.27%379.34K
BANK OF NEW YORK MELLON CORP86.10K86.10KNew371.53K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Orchestra BioMed (OBIO) Stock Insights

OBIO$5.99+0.21 +3.63%

$360.03M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History